Siltuximab
| Siltuximab | |
|---|---|
| Term | Siltuximab |
| Short definition | Siltuximab - (pronounced) (sil-TUK-sih-mab) A drug used to treat a rare condition called multicentric Castleman disease in patients who are not infected with HIV or human herpesvirus 8. It is also being studied to treat some cancers and other conditions. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Siltuximab - (pronounced) (sil-TUK-sih-mab) A drug used to treat a rare condition called multicentric Castleman disease in patients who are not infected with HIV or human herpesvirus 8. It is also being studied to treat some cancers and other conditions. Siltuximab attaches to a protein called interleukin-6 (IL-6), which is made by some white blood cells and other cells in the body. Siltuximab can help reduce inflammation and stop the growth of cancerous or abnormal blood cells. It's a type of monoclonal antibody. Also referred to as anti-IL-6 chimeric monoclonal antibody, cCLB8, CNTO 328 and Sylvant
External links
- Medical encyclopedia article on Siltuximab
- Wikipedia's article - Siltuximab
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski